本頁面由Tiger Trade Technology Pte. Ltd.提供服務

百濟神州

354.48
-4.5700-1.27%
盤後354.480.00000.00%16:57 EST
成交量:14.92萬
成交額:5,317.30萬
市值:421.83億
市盈率:681.17
高:365.60
開:359.05
低:352.93
收:359.05
52周最高:385.22
52周最低:196.45
股本:1.19億
流通股本:7,564.19萬
量比:1.10
換手率:0.20%
股息:- -
股息率:- -
每股收益(TTM):0.5204
每股收益(LYR):-6.1240
淨資產收益率:1.81%
總資產收益率:1.69%
市淨率:10.22
市盈率(LYR):-57.88

資料載入中...

2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

關聯方擬減持公告

Form 144 | BeOne Medicines Ltd. 高管 Xiaobin Wu 擬減持3991股,總價約151.83萬美元
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 | BeOne Medicines Ltd.高管 PAN-OYLER FOUNDATION 擬減持1204股,總價約40萬美元
2025/09/16

關聯方擬減持公告

Form 144 | BeOne Medicines高管John V Oyler擬減持27803股,總價約923.81萬美元
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/29

重要事件披露

Form 8-K - Current report
2025/08/25

重要事件披露

Form 8-K - Current report